Metadata
Author: Literature
Data
English[en]
The combination of velpatasvir, an NS5A inhibitor, and sofosbuvir is effective for all HCV genotypes.
Spanish[es]
La combinación de velpatavir, un inhibidor de NS5A, y sofosbuvir es eficaz para todos los genotipos de HCV.